Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term results of continuous treatment with recombinant interferon-a in patients with metastatic carcinoid tumors???an antiangiogenic effect?

1 Feb 1996

Abstract excerpt

This study investigated the efficacy of long-term continuous and dose-escalated interferon-alpha (IFN) treatment in patients with progressive carcinoid tumors. In this single-institution, phase II study 16 chemotherapy-naive, eligible patients were entered. Interferon treatment consisted on 5 MIU IFN three times weekly s.c. until radiologic progression. In case of progression the dose was increased to 10 MIU....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8740722
DOI: 10.1097/00001813-199602000-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Long-term results of continuous treatment with recombinant interferon-a in patients with metastatic carcinoid tumors???an antiangiogenic effect?PMID 8740722Read ↗

The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results.Semantic proximity Read ↗

Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanomaSemantic proximity Read ↗

Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma.Semantic proximity Read ↗

Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.Semantic proximity Read ↗

Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms.Semantic proximity Read ↗

The Biology of Myxofibrosarcoma: State of the Art and Future Perspectives.Semantic proximity Read ↗

Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implicationsSemantic proximity Read ↗

Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.